• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译后修饰对α-突触核蛋白在帕金森病发病机制中的作用

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases.

作者信息

Zhang Jiaming, Li Xiaoping, Li Jia-Da

机构信息

Center for Reproductive Medicine, The First Affiliated Hospital, University of South China, Hengyang, China.

Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha, China.

出版信息

Front Neurosci. 2019 Apr 18;13:381. doi: 10.3389/fnins.2019.00381. eCollection 2019.

DOI:10.3389/fnins.2019.00381
PMID:31057362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6482271/
Abstract

Parkinson's disease is the second most common neurodegenerative disorder. Although the pathogenesis of Parkinson's disease is not entirely clear, the aberrant aggregation of α-synuclein has long been considered as an important risk factor. Elucidating the mechanisms that influence the aggregation of α-synuclein is essential for developing an effective diagnostic, preventative and therapeutic strategy to treat this devastating disease. The aggregation of α-synuclein is influenced by several post-translational modifications. Here, we summarized the major post-translational modifications (phosphorylation, ubiquitination, truncation, nitration, -GlcNAcylation) of α-synuclein and the effect of these modifications on α-synuclein aggregation, which may provide potential targets for future therapeutics.

摘要

帕金森病是第二常见的神经退行性疾病。尽管帕金森病的发病机制尚不完全清楚,但α-突触核蛋白的异常聚集长期以来一直被认为是一个重要的风险因素。阐明影响α-突触核蛋白聚集的机制对于制定有效的诊断、预防和治疗策略以治疗这种毁灭性疾病至关重要。α-突触核蛋白的聚集受几种翻译后修饰的影响。在这里,我们总结了α-突触核蛋白的主要翻译后修饰(磷酸化、泛素化、截短、硝化、O-连接N-乙酰葡糖胺化)以及这些修饰对α-突触核蛋白聚集的影响,这可能为未来的治疗提供潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6663/6482271/d3fc47ba0c03/fnins-13-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6663/6482271/d3fc47ba0c03/fnins-13-00381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6663/6482271/d3fc47ba0c03/fnins-13-00381-g001.jpg

相似文献

1
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases.翻译后修饰对α-突触核蛋白在帕金森病发病机制中的作用
Front Neurosci. 2019 Apr 18;13:381. doi: 10.3389/fnins.2019.00381. eCollection 2019.
2
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.翻译:翻译后修饰在调节α-突触核蛋白的结构、功能和毒性中的作用:对帕金森病发病机制和治疗的影响。
Prog Brain Res. 2010;183:115-45. doi: 10.1016/S0079-6123(10)83007-9.
3
Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease.α-突触核蛋白相关翻译后修饰在帕金森病中的作用。
ACS Chem Neurosci. 2021 Apr 7;12(7):1061-1071. doi: 10.1021/acschemneuro.1c00028. Epub 2021 Mar 26.
4
Post-translational modification of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的翻译后修饰
Brain Res. 2015 Dec 2;1628(Pt B):247-253. doi: 10.1016/j.brainres.2015.06.002. Epub 2015 Jun 14.
5
Targeting α-synuclein post-translational modifications in Parkinson's disease.靶向帕金森病中α-突触核蛋白的翻译后修饰。
Behav Brain Res. 2023 Feb 15;439:114204. doi: 10.1016/j.bbr.2022.114204. Epub 2022 Nov 11.
6
Enzymatic O-GlcNAcylation of α-synuclein reduces aggregation and increases SDS-resistant soluble oligomers.α-突触核蛋白的酶促O-连接N-乙酰葡糖胺化减少聚集并增加耐十二烷基硫酸钠的可溶性寡聚体。
Neurosci Lett. 2017 Aug 10;655:90-94. doi: 10.1016/j.neulet.2017.06.034. Epub 2017 Jul 1.
7
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.α-突触核蛋白的 O-连接糖基化改变了其聚集和毒性,揭示了某些残基可能是帕金森病的潜在抑制剂。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1511-1519. doi: 10.1073/pnas.1808845116. Epub 2019 Jan 16.
8
Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.利用合成和半合成修饰的 α-突触核蛋白探索帕金森病发病机制中的翻译后修饰作用。
ACS Chem Neurosci. 2019 Feb 20;10(2):910-921. doi: 10.1021/acschemneuro.8b00447. Epub 2019 Jan 18.
9
O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding.丝氨酸87位点的α-突触核蛋白O-连接N-乙酰葡糖胺化减少聚集而不影响膜结合。
ACS Chem Biol. 2017 Apr 21;12(4):1020-1027. doi: 10.1021/acschembio.7b00113. Epub 2017 Feb 22.
10
Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.当前技术揭示了翻译后修饰(PTMs)作为神经退行性变关键因素的重要性。
Biomolecules. 2024 Jan 16;14(1):118. doi: 10.3390/biom14010118.

引用本文的文献

1
Changes of α-Synuclein Localization in a Neuronal Precursor Graft in the Rat Model of 6-OHDA-Induced Parkinsonism.6-羟基多巴胺诱导的帕金森病大鼠模型中神经元前体细胞移植后α-突触核蛋白定位的变化
Bull Exp Biol Med. 2025 Aug 29. doi: 10.1007/s10517-025-06469-w.
2
Lipid packing defects are necessary and sufficient for membrane binding of α-synuclein.脂质堆积缺陷对于α-突触核蛋白的膜结合是必要且充分的。
Commun Biol. 2025 Aug 7;8(1):1179. doi: 10.1038/s42003-025-08622-7.
3
A manifesto for Alzheimer's disease drug discovery in the era of disease-modifying therapies.

本文引用的文献

1
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.α-突触核蛋白的 O-连接糖基化改变了其聚集和毒性,揭示了某些残基可能是帕金森病的潜在抑制剂。
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1511-1519. doi: 10.1073/pnas.1808845116. Epub 2019 Jan 16.
2
Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.帕金森病相关突变和 N 端乙酰化在 3,4-二羟苯乙酸诱导的α-突触核蛋白寡聚化中的作用。
ACS Chem Neurosci. 2019 Jan 16;10(1):690-703. doi: 10.1021/acschemneuro.8b00498. Epub 2018 Nov 5.
3
疾病修饰疗法时代阿尔茨海默病药物研发宣言。
Mol Neurodegener. 2025 Aug 6;20(1):88. doi: 10.1186/s13024-025-00872-7.
4
Research progress of cell treatment strategy in Parkinson's disease.帕金森病细胞治疗策略的研究进展
Neurosci Appl. 2024 Mar 30;3:104061. doi: 10.1016/j.nsa.2024.104061. eCollection 2024.
5
Detecting alpha-synuclein aggregates with small molecules on single-molecule array.在单分子阵列上用小分子检测α-突触核蛋白聚集体。
Chem Sci. 2025 Jun 16. doi: 10.1039/d4sc07649d.
6
Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.帕金森病中的神经退行性变模型:神经元死亡的细胞和分子途径。
Behav Brain Funct. 2025 May 31;21(1):14. doi: 10.1186/s12993-025-00279-w.
7
Exploring α-Syn's Functions Through Ablation Models: Physiological and Pathological Implications.通过基因敲除模型探索α-突触核蛋白的功能:生理和病理意义
Cell Mol Neurobiol. 2025 May 19;45(1):44. doi: 10.1007/s10571-025-01560-2.
8
Ligands for Protein Fibrils of Amyloid-β, α-Synuclein, and Tau.淀粉样β蛋白、α-突触核蛋白和tau蛋白原纤维的配体
Chem Rev. 2025 Jun 11;125(11):5282-5348. doi: 10.1021/acs.chemrev.4c00838. Epub 2025 May 6.
9
Alpha-synuclein pathology and Parkinson's disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches.α-突触核蛋白病理学与帕金森病相关嗅觉功能障碍:临床前模型与治疗方法的最新进展
Mamm Genome. 2025 Apr 28. doi: 10.1007/s00335-025-10128-w.
10
Aggregation of α-synuclein splice isoforms through a phase separation pathway.α-突触核蛋白剪接异构体通过相分离途径聚集。
Sci Adv. 2025 Apr 18;11(16):eadq5396. doi: 10.1126/sciadv.adq5396. Epub 2025 Apr 16.
Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention.
帕金森病中的小胶质细胞反应:α-突触核蛋白干预
Front Cell Neurosci. 2018 Aug 6;12:247. doi: 10.3389/fncel.2018.00247. eCollection 2018.
4
SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation.SUMOylation 和泛素化相互调节 α-突触核蛋白的降解和病理性聚集。
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13176-13181. doi: 10.1073/pnas.1704351114. Epub 2017 Nov 27.
5
Enzymatic O-GlcNAcylation of α-synuclein reduces aggregation and increases SDS-resistant soluble oligomers.α-突触核蛋白的酶促O-连接N-乙酰葡糖胺化减少聚集并增加耐十二烷基硫酸钠的可溶性寡聚体。
Neurosci Lett. 2017 Aug 10;655:90-94. doi: 10.1016/j.neulet.2017.06.034. Epub 2017 Jul 1.
6
Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease.定量蛋白质组学鉴定出阿尔茨海默病中结构、突触和记忆相关蛋白的O-连接N-乙酰葡糖胺化改变。
J Pathol. 2017 Sep;243(1):78-88. doi: 10.1002/path.4929. Epub 2017 Jul 28.
7
O-GlcNAcylation of α-Synuclein at Serine 87 Reduces Aggregation without Affecting Membrane Binding.丝氨酸87位点的α-突触核蛋白O-连接N-乙酰葡糖胺化减少聚集而不影响膜结合。
ACS Chem Biol. 2017 Apr 21;12(4):1020-1027. doi: 10.1021/acschembio.7b00113. Epub 2017 Feb 22.
8
Epidemiology of Parkinson's disease.帕金森病的流行病学
J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1.
9
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.多巴胺衍生的α-突触核蛋白寡聚体损害突触囊泡的生理功能。
Sci Rep. 2017 Jan 13;7:40699. doi: 10.1038/srep40699.
10
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.Endosulfine-alpha 抑制膜诱导的 α-突触核蛋白聚集,并防止 α-突触核蛋白神经毒性。
Acta Neuropathol Commun. 2017 Jan 10;5(1):3. doi: 10.1186/s40478-016-0403-7.